Evidence map›Paper›PMID 9566610›Full record

ReviewNeurochemical research1998

In vitro reconstitution of neurotransmitter release.

Y Dunant, M Israël

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Synaptosomes and Metamodulation of Receptors.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Y DunantDépartement de Pharmacologie, Université de Genève, Centre Médical Universitaire, Switzerland. dunant@cmu.unige.ch
M Israël
Laboratoire de Neurobiologie Cellulaire et Moléculaire · FRUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vesicular hypothesis has stimulated fruitful investigations on many secreting systems. In the case of rapid synaptic transmission, however, the hypothesis has been found difficult to reconcile with a number of well established observations. Brief impulses of transmitter molecules (quanta) are emitted from nerve terminals at the arrival of an action potential by a mechanism which is under the control of multiple regulations. It is therefore not surprising that quantal release could be disrupted by experimental manipulation of a variety of cellular processes, such as a) transmitter uptake, synthesis, or transport, b) energy supply, c) calcium entry, sequestration and extrusion, d) exo- or endocytosis, e) expression of vesicular and plasmalemmal proteins, f) modulatory systems and second messengers, g) cytoskeleton integrity, etc. Hence, the approaches by "ablation strategy" do not provide unequivocal information on the final step of the release process since there are so many ways to stop the release. We propose an alternate approach: the "reconstitution strategy". To this end, we developed several preparations for determining the minimal system supporting Ca2+-dependent transmitter release. Release was reconstituted in proteoliposomes, Xenopus oocytes and transfected cell lines. Using these systems, it appears that a presynaptic plasmalemmal proteolipid, that we called mediatophore should be considered as a key molecule for the generation of transmitter quanta in natural synapses.

Indexed as

AnimalsBrainCalciumEnergy MetabolismHumansModels, NeurologicalNeurotransmitter AgentsQuantum TheorySynapsesSynaptosomesCalciumNeurotransmitter Agents

Identifiers

PMID9566610
OpenAlexW107779369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.